血管性假性血友病因子及其裂解酶在原发性肝癌患者中的变化及临床意义
出处
《临床荟萃》
CAS
北大核心
2008年第18期1338-1339,共2页
Clinical Focus
基金
广西自然科学基金(0339053)
参考文献6
-
1Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura[J]. N Engl J Med,1998,339(22) :1585-1594.
-
2Koo BH,Oh D, Chung SY, et al. Deficiency of von Willebrand factor-cleaving protease activity in the plasma of malignant patients[J]. Thromb Res,2002,105(6) : 471-476.
-
3Blot E, Decaudin D, Veyradier A, et al. Cancer-related thombotic microangiopathy secondary to yon Willebrand factorcleaving protease deficiency[J]. Thromb Res,2002,106(2):127- 130.
-
4林发全,李明芬,刘倩,黎肇炎.血管性假性血友病因子裂解酶活性检测方法的建立及其临床应用[J].南方医科大学学报,2007,27(8):1176-1179. 被引量:5
-
5Tsai HM. Physiologic cleavage of yon Willebrand factor by a plasma protease is dependent on its conformation and requires calciumion[J]. Blood,1996,87(10) :4235-4244.
-
6Sadler JE. Biochemistry and genetics of von Willebrand factor [J]. A Rev Biochem,1998,67(4) :395-408.
二级参考文献13
-
1高维强,苏健,邢秀萍,王京华,白霞,王兆钺,阮长耿.von Willebrand因子裂解酶活性水平的检测及其临床应用[J].中国实验血液学杂志,2004,12(6):726-729. 被引量:9
-
2潘剑罡,刘洲.急性脑梗死患者细胞粘附分子-1、P-选择素和von Willebrand因子含量变化及其临床意义研究[J].神经疾病与精神卫生,2005,5(2):92-94. 被引量:9
-
3Furlan M,Robles R,Lamie B.Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis[J].Blood,1996,87(11):4223-34.
-
4Sadler JE.Biochemistry and genetics of von Willebrand factor[J].Annu Rev Biochem,1998,67:395-24.
-
5Schneppenheim R,Budde U,Obser T,et al.Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease[J].Blood,2001,97(7):2059-66.
-
6Furlan M,Robles R,Galbusera M,et al.Von Willebrand factorcleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome[J].N Eng J Med,1998,339 (22):1578-84.
-
7Tsai HM,Sussman Ⅱ,Nagel RL.Shear stress enhances the proteolysis of von Willebrand factor in normal plasma[J].Blood,1994,83(8):2171-9.
-
8Tsai HM.Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion[J].Blood,1996,87(10):4235-44.
-
9Tsai HM,Lian EC.Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura[J].N Engl J Med,1998,339(22):1585-94.
-
10He S,Cao H,Magnusson CG,et al.Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor protein[J].Thromb Res,2001,103(3):241-8.
共引文献4
-
1曾志羽,刘倩,郑慧蕾,韦恒,马国添,林发全.高血压病患者血浆血管性血友病因子及其裂解酶的变化[J].广西医科大学学报,2009,26(3):346-348. 被引量:12
-
2曾志羽,欧阳玲莉,李明芬,黄小琪.2型糖尿病合并冠心病患者CD62P、CD63、vWF与vWF-cp检测及其临床意义[J].内科,2009,4(4):508-510. 被引量:1
-
3潘爱萍,林发全,黄小琪,李明芬,刘倩,罗曙光.原发性肝癌患者血小板活化与血管内皮损伤标志物检测及临床意义[J].中国中医药咨讯,2009,1(4):12-13. 被引量:1
-
4李明芬,黄晓琪,林英辉,林发全,刘倩.急性脑梗死患者血小板活化与血管内皮损伤标志物检测及其临床意义[J].中国实验诊断学,2011,15(7):1119-1121. 被引量:26
-
1陈亚利,许姗姗,张晶.vWF及ADAMTS13在肝脏疾病中的意义[J].肝脏,2016,21(4):316-319. 被引量:2
-
2曹文静,ZHENG X Long.血管性血友病因子裂解酶的研究进展[J].中华检验医学杂志,2008,31(6):704-707. 被引量:1
-
3胡上高,周建耀.过敏性紫癜患者血浆血管性假血友病因子的变化及临床意义[J].临床荟萃,2009,24(2):147-147.
-
4高维强,周晓俊,白霞,苏健,阮长耿.原发性肝癌血管性血友病因子裂解酶的表达水平及意义[J].中华肝脏病杂志,2005,13(10):795-796. 被引量:3
-
5陈劲松,匡希斌,陈海燕,陈琳.急性冠状动脉综合征血浆血管性血友病因子及其裂解酶[J].岭南心血管病杂志,2007,13(2):118-121.
-
6程阳.急性冠脉综合征的治疗[J].中国实用内科杂志,2007,27(S1):324-324.
-
7何达,杜延玲.血小板活化标志物CD62p、PAC-1在呼吸系统疾病中的研究进展[J].临床肺科杂志,2014,19(3):516-517. 被引量:3
-
8刘世雷,刘相飞,丁慧芳.血管性血友病因子、vWF-cp与老年人冠心病、动脉粥样硬化斑块的关系[J].中国老年学杂志,2013,33(18):4577-4578. 被引量:3
-
9孙川,张英辉,卓曼云,孟杰.血栓性血小板减少性紫癜患者的临床治疗[J].华南国防医学杂志,2014,28(9):917-919. 被引量:1
-
10任丽,张楠,周广喜.以神经系统症状首发的血栓性血小板减少性紫癜一例报道并文献复习[J].中华神经医学杂志,2010,9(10):1067-1068. 被引量:2